Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Zimmer Biomet Holdings Inc. (ZBH) reported that its second-quarter net loss was $206.6 million or $1.00 per share compared to net income of $133.7 million or $0.65 per share in the prior year.


RTTNews | Aug 4, 2020 06:48AM EDT

06:47 Tuesday, August 4, 2020 (RTTNews.com) - Zimmer Biomet Holdings Inc. (ZBH) reported that its second-quarter net loss was $206.6 million or $1.00 per share compared to net income of $133.7 million or $0.65 per share in the prior year.

Second quarter performance was negatively impacted by COVID-19, which reached a pandemic level in March and has resulted in a global decline in elective procedure volumes. The deepest decline in those procedures to-date was seen by the company in April 2020, with incremental improvement in May and June, the company said.

Adjusted earnings per share were $0.05 for the second quarter, a decrease of 97.4% from the prior year period. Analysts polled by Thomson Reuters expected the company to report a loss of $0.73 per share for the quarter. Analysts' estimates typically exclude special items.

Net sales were $1.226 billion, a decrease of 38.3% from the prior year period, and a decrease of 38.0% on a constant currency basis. Analysts expected revenue of $909.41 million for the quarter.

Read the original article on RTTNews ( https://www.rttnews.com/3117805/zimmer-biomet-q2-results-top-estimates.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC